NYMC Faculty Publications
DOI
10.18632/oncotarget.24917
Journal Title
Oncotarget
First Page
24272
Last Page
24282
Document Type
Article
Publication Date
3-1-2018
Department
Pathology, Microbiology and Immunology
Abstract
The majority of breast cancers (90-95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous studies have demonstrated that up to 50% of the breast tumor comprise of tumor-associated macrophages (TAMs) and increased TAM infiltration has been associated with poor patient prognosis. Furthermore, breast cancer associated deaths are predominantly attributed to invasive cancers and metastasis with epithelial-mesenchymal transition (EMT) being implicated. In this study, we investigated the effects of cellular crosstalk between TAMs and breast cancer using an in vitro model system. M1 polarized THP-1 macrophage conditioned media (CM) was generated and used to evaluate cellular and functional changes of breast cancer lines T47D and MCF-7. We observed that T47D and MCF-7 exhibited a partial EMT phenotype in the presence of activated THP-1 CM. Additionally, MCF-7 displayed a significant increase in migratory and invasive properties. We conclude that M1 secretory factors can promote a partial EMT of epithelial-like breast cancer cells. The targeting of M1 macrophages or their secretory components may inhibit EMT and limit the invasive potential of breast cancer.
Recommended Citation
Bednarczyk, R., Tuli, N., Hanly, E., Rahoma, G., Mittelman, A., Geliebter, J., & Tiwari, R. K. (2018). Macrophage Inflammatory Factors Promote Epithelial-Mesenchymal Transition in Breast Cancer. Oncotarget, 9 (36), 24272-24282. https://doi.org/10.18632/oncotarget.24917
Publisher's Statement
Originally published in Oncotarget, 9(36), 24272-24282. The original material can be found here.
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.
Comments
Please see the work itself for the complete list of authors.